Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (111-120 of 205) with videos related to

Pageof 21
Sort By:
Blood|February 28, 2002
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cellsMassimo Vitale, Jacques Zimmer, Roberta Castriconi, et al.
European Journal of Immunology|February 11, 2014
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cellsFrancesca Bellora, Roberta Castriconi, Alessandra Dondero, et al.
European Journal of Immunology|October 6, 2007
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicityRoberta Castriconi, Alessandra Dondero, Francesca Negri, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2003
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cellsRoberta Castriconi, Claudia Cantoni, Mariella Della Chiesa, et al.
Oncotarget|May 12, 2015
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancerChristine Pasero, Gwenaëlle Gravis, Samuel Granjeaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for stainingMichela Falco, Elisa Romeo, Stefania Marcenaro, et al.
The Journal of Investigative Dermatology|April 17, 2004
CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndromeEwa Poszepczynska-Guigné, Valérie Schiavon, Michel D'Incan, et al.
Mucosal Immunology|February 14, 2019
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human deciduaPaola Vacca, Silvia Pesce, Marco Greppi, et al.
Cancer Research|September 23, 2011
Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognitionEmilie Mamessier, Aude Sylvain, François Bertucci, et al.
European Journal of Immunology|November 25, 2003
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicityEmanuela Marcenaro, Raffaella Augugliaro, Michela Falco, et al.
Pageof 21

Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
Blood|February 28, 2002
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cellsMassimo Vitale, Jacques Zimmer, Roberta Castriconi, et al.
European Journal of Immunology|February 11, 2014
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cellsFrancesca Bellora, Roberta Castriconi, Alessandra Dondero, et al.
European Journal of Immunology|October 6, 2007
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicityRoberta Castriconi, Alessandra Dondero, Francesca Negri, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2003
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cellsRoberta Castriconi, Claudia Cantoni, Mariella Della Chiesa, et al.
Oncotarget|May 12, 2015
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancerChristine Pasero, Gwenaëlle Gravis, Samuel Granjeaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for stainingMichela Falco, Elisa Romeo, Stefania Marcenaro, et al.
The Journal of Investigative Dermatology|April 17, 2004
CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndromeEwa Poszepczynska-Guigné, Valérie Schiavon, Michel D'Incan, et al.
Mucosal Immunology|February 14, 2019
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human deciduaPaola Vacca, Silvia Pesce, Marco Greppi, et al.
Cancer Research|September 23, 2011
Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognitionEmilie Mamessier, Aude Sylvain, François Bertucci, et al.
European Journal of Immunology|November 25, 2003
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicityEmanuela Marcenaro, Raffaella Augugliaro, Michela Falco, et al.
Pageof 21